Company Performance - Nu Skin Enterprises (NUS) reported quarterly earnings of $0.09 per share, exceeding the Zacks Consensus Estimate of $0.05 per share, but down from $0.37 per share a year ago, indicating an earnings surprise of 80% [1] - The company posted revenues of $417.31 million for the quarter ended March 2024, missing the Zacks Consensus Estimate by 3.09% and down from $481.46 million year-over-year [1] - Over the last four quarters, Nu Skin has surpassed consensus EPS estimates three times but has only topped consensus revenue estimates once [1] Stock Performance and Outlook - Nu Skin shares have declined approximately 36.9% since the beginning of the year, contrasting with the S&P 500's gain of 8.8% [2] - The future performance of Nu Skin's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [2] Earnings Estimates and Industry Context - The current consensus EPS estimate for the upcoming quarter is $0.37 on revenues of $458.3 million, and for the current fiscal year, it is $1.13 on revenues of $1.81 billion [4] - The Cosmetics industry, to which Nu Skin belongs, is currently ranked in the bottom 35% of over 250 Zacks industries, suggesting potential challenges for stock performance [4] - The Zacks Rank for Nu Skin is currently 3 (Hold), indicating that shares are expected to perform in line with the market in the near future [3]
Nu Skin Enterprises (NUS) Surpasses Q1 Earnings Estimates